Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amir Tahmasb Fathi, M.D.


This page shows the publications co-authored by Amir Fathi and Vivek Upadhyay.
Connection Strength

  1. Induction chemotherapy in acute myeloid leukaemia: origins and emerging directions. Curr Opin Hematol. 2018 03; 25(2):67-74.
    View in: PubMed
    Score: 0.750
  2. Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions. Pharmacol Ther. 2017 Sep; 177:123-128.
    View in: PubMed
    Score: 0.702
  3. The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies. Curr Hematol Malig Rep. 2016 06; 11(3):165-74.
    View in: PubMed
    Score: 0.166
  4. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Blood. 2019 08 22; 134(8):678-687.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.